Proton pump inhibitors may hinder hypophosphatemic effect of lanthanum carbonate, but not of ferric citrate hydrate or sucroferric oxyhydroxide, in hemodialysis patients

Because end-stage renal disease patients undergoing hemodialysis frequently take acid suppressants for the treatment or prevention of gastrointestinal diseases, it is important to clarify the drug-interactions between acid suppressants and phosphate binders on the control of serum phosphate levels....

Descripción completa

Detalles Bibliográficos
Autores principales: Minakuchi, Hitoshi, Yoshida, Tadashi, Kaburagi, Noriko, Fujino, Teppei, Endo, Sho, Takemitsu, Tomoko Yamashita, Yamashita, Norimasa, Itoh, Hiroshi, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472469/
https://www.ncbi.nlm.nih.gov/pubmed/32779954
http://dx.doi.org/10.1080/0886022X.2020.1803085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472469/
https://www.ncbi.nlm.nih.gov/pubmed/32779954
http://dx.doi.org/10.1080/0886022X.2020.1803085

Ejemplares similares